Covidien (COV) says it will buy privately-held superDimension Ltd., an Israel-based respiratory...


Covidien (COV) says it will buy privately-held superDimension Ltd., an Israel-based respiratory systems maker, for ~$300M to gain access to its iLogic System, which provides minimally invasive access to lesions deep in the lung and lymph nodes.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs